GRANULES - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 3.7
| Stock Code | GRANULES | Market Cap | 17,636 Cr. | Current Price | 712 ₹ | High / Low | 731 ₹ |
| Stock P/E | 43.0 | Book Value | 178 ₹ | Dividend Yield | 0.21 % | ROCE | 12.8 % |
| ROE | 10.5 % | Face Value | 1.00 ₹ | DMA 50 | 636 ₹ | DMA 200 | 578 ₹ |
| Chg in FII Hold | 1.76 % | Chg in DII Hold | -0.46 % | PAT Qtr | 99.0 Cr. | PAT Prev Qtr | 112 Cr. |
| RSI | 76.1 | MACD | 26.0 | Volume | 8,12,852 | Avg Vol 1Wk | 24,06,682 |
| Low price | 431 ₹ | High price | 731 ₹ | PEG Ratio | -6.71 | Debt to equity | 0.19 |
| 52w Index | 93.7 % | Qtr Profit Var | 36.1 % | EPS | 16.2 ₹ | Industry PE | 30.9 |
📊 Granules India shows moderate fundamentals with ROCE at 12.8% and ROE at 10.5%, which are below industry leaders. The company has manageable debt (0.19 debt-to-equity), ensuring financial stability. Dividend yield is very low at 0.21%, offering limited income. The P/E of 43.0 is higher than the industry average of 30.9, suggesting overvaluation. PEG ratio of -6.71 indicates weak growth prospects relative to valuation. Current price ₹712 is near its 52-week high (₹731), showing limited upside potential. RSI at 76.1 indicates overbought conditions, while MACD positive (26.0) suggests bullish momentum. Quarterly PAT declined from ₹112 Cr. to ₹99 Cr., raising concerns despite EPS of ₹16.2.
💡 Ideal Entry Zone: ₹630 – ₹670 (closer to 50 DMA support).
📈 Exit Strategy: Investors already holding should consider a medium-term horizon (2–3 years). Partial profit booking is advisable near ₹720–₹730 resistance levels. Long-term holding should be cautious given weak PEG ratio, modest ROE/ROCE, and limited dividend yield.
Positive
- Debt-to-equity ratio of 0.19 ensures financial stability.
- Institutional support with FII holdings up (+1.76%).
- Stock trading above DMA levels with bullish momentum indicators.
- EPS of ₹16.2 provides earnings visibility.
Limitation
- ROE (10.5%) and ROCE (12.8%) are modest compared to peers.
- High P/E (43.0) relative to industry average (30.9).
- Negative PEG ratio (-6.71) signals poor growth valuation.
- Dividend yield of only 0.21% offers negligible income.
- Quarterly PAT declined from ₹112 Cr. to ₹99 Cr.
Company Negative News
- Recent quarterly profit decline raises concerns about earnings consistency.
Company Positive News
- FII stake increased significantly (+1.76%), showing foreign investor confidence.
- Strong momentum indicators (RSI 76.1, MACD 26.0).
Industry
- Pharmaceutical sector remains resilient with long-term demand drivers.
- Industry P/E of 30.9 reflects moderate optimism in healthcare stocks.
Conclusion
⚠️ Granules India is financially stable but has modest profitability and stretched valuations. The stock is trading near its 52-week high, limiting upside potential. Ideal entry is near ₹630–₹670. Existing investors should hold cautiously for 2–3 years, with partial profit booking near ₹720–₹730 resistance levels.